Skip to main content
. 2021 Nov 8;11:686308. doi: 10.3389/fonc.2021.686308

Figure 6.

Figure 6

Trends of the main blood parameters according to clinical response. Twenty-four patients were considered eligible (three patients were excluded for concomitant hematological tumors, one for thalassemia major, and two for concomitant immunosuppressive therapy). For non-responders, data from the 6-month sampling are not available.